Actionnariat et activité des initiés pour Silence Therapeutics plc (SLN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $12.50 |
| Capitalisation | $590M |
| Bourse | NASDAQ |
| Pays | GB |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $39.0M | $42.7M | $21.5M | $13.5M | $27.4M | $73.5M | $54.8M | $54.4M | $96.9M | $11.3M |
| Placements à Court Terme | 0 | $319000 | $5.0M | $20.0M | $10.0M | 0 | $16.3M | 0 | $20.8M | $73.8M |
| Créances | $810000 | $2.0M | $2.4M | $4000 | $29.3M | $331000 | $915000 | $19.0M | $776375 | $24.6M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $42.0M | $45.5M | $29.5M | $37.5M | $76.4M | $86.3M | $96.7M | $81.6M | $149.7M | $118.7M |
| Immobilisations Corporelles | $1.4M | $1.2M | $921000 | $611000 | $1.1M | $1.9M | $2.2M | $2.3M | $1.6M | $1.7M |
| Goodwill | $7.7M | $8.0M | $8.1M | $7.7M | $8.1M | $7.6M | $8.0M | $10.0M | $7.5M | $10.6M |
| Actifs Incorporels | $45000 | $28000 | $64000 | $34000 | $17000 | $24000 | $320000 | $362000 | $249206 | $288000 |
| Actifs Totaux | $55.8M | $55.0M | $38.9M | $46.1M | $86.0M | $96.2M | $107.5M | $94.5M | $161.9M | $131.4M |
| Dettes Fournisseurs | $528000 | $462000 | $1.1M | $1.8M | $2.3M | $4.1M | $3.2M | $2.6M | $3.0M | $4.4M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $1.6M | $2.7M | $3.8M | $9.7M | $25.6M | $15.2M | $21.9M | $17.7M | $13.4M | $13.6M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.6M | $2.7M | $3.8M | $25.2M | $76.9M | $87.7M | $85.4M | $77.1M | $54.8M | $69.1M |
| Réserves | -$116.0M | -$116.4M | -$133.8M | -$152.0M | -$184.2M | -$223.0M | -$263.3M | -$431.9M | -$378.6M | -$562.6M |
| Capitaux Propres | $54.2M | $52.4M | $35.1M | $20.9M | $9.1M | $8.5M | $22.1M | $22.0M | $107.0M | $62.3M |
| Dette Totale | 0 | 0 | 0 | $287000 | $341000 | $137000 | $446000 | $273808 | $93452 | $160000 |
| Dette Nette | -$39.0M | -$43.1M | -$26.5M | -$33.2M | -$37.1M | -$73.4M | -$70.7M | -$54.2M | -$117.6M | -$85.0M |
| Fonds de Roulement | $40.4M | $42.9M | $25.7M | $27.8M | $50.8M | $71.2M | $74.7M | $64.0M | $136.2M | $105.0M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 7.42 |
Rentabilité
| Rentabilité des capitaux propres | -106.94% |
| Rentabilité du capital investi | -71.25% |
| Rentabilité des actifs | -56.34% |
| Marge brute | 51.00% |
| Marge opérationnelle | -10880.25% |
| Marge nette | -9759.23% |
Entreprises liées: ACIU · ALDX · AMRN · ANRO · CAPR · CTNM · KYTX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de SLN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions